EDGAR Filing Documents for 0000903423-17-000459

Form 3 - Initial statement of beneficial ownership of securities:

SEC Accession No. 0000903423-17-000459

Filing Date

2017-07-10

Accepted

2017-07-10 19:23:30

Documents

Period of Report

2017-07-01

Document Format Files

Seq	Description	Document	Type	Size
1	OWNERSHIP DOCUMENT	shabetmyovf3.html	3
1	OWNERSHIP DOCUMENT	shabetmyovf3.xml	3	5118
	Complete submission text file	0000903423-17-000459.txt		6468

Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS

Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS (441) 824-8101

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VIKING GLOBAL INVESTORS LP 280 PARK AVENUE NEW YORK NY 10017

Business Address

Type: 3 | Act: 34 | File No.: 001-37929 | Film No.: 17958841